CHES Faculty Member Dr. Liping Zhao has developed an early treatment that will aid in preventing complications resulting from COVID19 infection. The formula has approval from the FDA for clinical trials commencing this month. To read more about Dr. Zhao's work, please check out: https://www.rutgers.edu/news/rutgers-researcher-invents-microbiota-formula-help-high-risk-patients-fight-covid-19
News Item
CHES Faculty Member Contributes to COVID19 Treatments
- Details